{"disease":{"id":"high-risk-melanoma","name":"high risk melanoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00636168","title":"Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1211,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}